BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26764252)

  • 1. Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients.
    Königsbrügge O; Posch F; Riedl J; Reitter EM; Zielinski C; Pabinger I; Ay C
    Oncologist; 2016 Feb; 21(2):252-7. PubMed ID: 26764252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
    Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein.
    Kunutsor SK; Seidu S; Katechia DT; Laukkanen JA
    Ann Med; 2018 May; 50(3):240-248. PubMed ID: 29448840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality.
    Königsbrügge O; Lötsch F; Zielinski C; Pabinger I; Ay C
    Thromb Res; 2014 Jul; 134(1):44-9. PubMed ID: 24792954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality.
    Riedl J; Posch F; Königsbrügge O; Lötsch F; Reitter EM; Eigenbauer E; Marosi C; Schwarzinger I; Zielinski C; Pabinger I; Ay C
    PLoS One; 2014; 9(10):e111440. PubMed ID: 25347577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
    Königsbrügge O; Pabinger I; Ay C
    Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
    Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
    Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.
    Posch F; Riedl J; Reitter EM; Kaider A; Zielinski C; Pabinger I; Ay C
    Thromb Haemost; 2016 Apr; 115(4):817-26. PubMed ID: 26738412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort.
    Blix K; Gran OV; Severinsen MT; Cannegieter SC; Jensvoll H; Overvad K; Hammerstrøm J; Tjønneland A; Naess IA; Braekkan SK; Rosendaal FR; Kristensen SR; Hansen JB
    J Thromb Haemost; 2018 Jul; 16(7):1327-1335. PubMed ID: 29691978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
    Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
    Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin and risk of venous thromboembolism.
    Folsom AR; Lutsey PL; Heckbert SR; Cushman M
    Thromb Haemost; 2010 Jul; 104(1):100-4. PubMed ID: 20390234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome.
    Gyamlani G; Molnar MZ; Lu JL; Sumida K; Kalantar-Zadeh K; Kovesdy CP
    Nephrol Dial Transplant; 2017 Jan; 32(1):157-164. PubMed ID: 28391310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients.
    Königsbrügge O; Riedl J; Grilz E; Wiltschke C; Zielinski C; Pabinger I; Ay C
    Thromb Res; 2016 Apr; 140 Suppl 1():S176. PubMed ID: 27161690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of platelet activation markers with cancer-associated venous thromboembolism.
    Riedl J; Hell L; Kaider A; Koder S; Marosi C; Zielinski C; Panzer S; Pabinger I; Ay C
    Platelets; 2016; 27(1):80-5. PubMed ID: 25970326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality.
    Ay C; Posch F; Kaider A; Zielinski C; Pabinger I
    J Thromb Haemost; 2015 Mar; 13(3):390-7. PubMed ID: 25529107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis risk and survival in cancer patients with elevated C-reactive protein.
    Kanz R; Vukovich T; Vormittag R; Dunkler D; Ay C; Thaler J; Haselböck J; Scheithauer W; Zielinski C; Pabinger I
    J Thromb Haemost; 2011 Jan; 9(1):57-63. PubMed ID: 20874781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.
    Olson NC; Cushman M; Lutsey PL; McClure LA; Judd S; Tracy RP; Folsom AR; Zakai NA
    J Thromb Haemost; 2014 Dec; 12(12):1993-2001. PubMed ID: 25292154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.